IMS has launched the report “Generic Medicines: essential contributors to the long-term health of society - sector sustainability challenges in Europe”.
In the report, IMS's Alan Sheppard looks at the sustainability of the generics sector and assesses its benefits to the provision of healthcare across Europe.
According to the report, over half of the volume of medicines are supplied as generics medicines but this represents just 18% in value terms.
The European Generic Medicines Association have estimated that, to date, generics medicines in the European Union have generated savings in the order of EUR30 billion.
Key takeaways from the report:
- Generic medicines provide an affordable, gold standard medication for many major illnesses
- Generic medicines allow access to medicines for a greater proportion of the population
- Generic medicines stimulate healthy competition with the branded sector
- Generic medicines deliver savings to national health bills
- Generic medicines are high quality products
The full report can be downloaded from IMS' website:
Generic Medicines: essential contributors to the long-term health of society - sector sustainability challenges in Europe (PDF, 1MB)
About IMS Health